The Trump administration is preparing to introduce a new Medicare pilot program that could dramatically reshape how healthcare decisions are made for millions of Americans. At the heart of the debate lies one critical question: which medical procedures will be affected, and how might patients’ access to care change?
For the first time in the history of traditional Medicare—not just Medicare Advantage—patients will be required to obtain prior authorization before undergoing specific medical procedures. This marks a significant shift in how care is delivered to seniors and vulnerable populations who rely on Medicare for essential treatments.
When and Where the Program Will Begin
The pilot program is scheduled to launch in January 2026 across six states: Arizona, New Jersey, Ohio, Oklahoma, Texas, and Washington. According to the Centers for Medicare & Medicaid Services (CMS), the initiative is designed to reduce fraud, waste, and unnecessary spending within the system.
With Medicare consuming nearly one-quarter of the federal budget, policymakers see it as a critical area for reform. Former President Donald Trump has repeatedly emphasized the need to rein in what he views as excessive and unnecessary expenditures within one of the government’s most expensive programs.
A New Role for AI and Private Contractors
What sets this pilot apart is its heavy reliance on private contractors and artificial intelligence (AI) tools to review and screen requests for medical procedures. While CMS has stressed that licensed clinicians will have the final say in approval or denial decisions, the initial process will be heavily influenced by automated systems.
This approach has raised concerns among patients and healthcare advocates, particularly because many of the targeted procedures are commonly used to manage chronic conditions affecting older adults. Critics fear that the added administrative burden could delay access to necessary treatments—or, in some cases, discourage patients from pursuing care altogether.
Medical Procedures Covered Under the Pilot
According to reporting by The New York Times journalist Teddy Rosenbluth, the following procedures will require prior authorization under the pilot program beginning in 2026:
-
Electrical Nerve Stimulators
-
Sacral Nerve Stimulation for Urinary Incontinence
-
Phrenic Nerve Stimulators
-
Deep Brain Stimulation for Essential Tremor and Parkinson’s Disease
-
Vagus Nerve Stimulation
-
Induced Lesions of Nerve Tracts
-
Epidural Steroid Injections for Pain Management (excluding facet joint injections)
-
Percutaneous Vertebral Augmentation (PVA) for Vertebral Compression Fracture (VCF)
-
Cervical Fusion
-
Arthroscopic Lavage and Arthroscopic Debridement for Osteoarthritic Knee
-
Hypoglossal Nerve Stimulation for Obstructive Sleep Apnea
-
Incontinence Control Devices
-
Diagnosis and Treatment of Impotence
-
Percutaneous Image-Guided Lumbar Decompression for Spinal Stenosis
-
Skin and Tissue Substitutes (in states with active Local Coverage Determinations)
What This Means for Patients
While the administration frames the program as a cost-saving and fraud-prevention measure, many patient advocates worry that it could place unnecessary hurdles between seniors and the treatments they depend on. The use of AI in initial decision-making adds an additional layer of uncertainty, leaving patients questioning whether technology—not medical judgment—will determine their access to care.
Why It Matters
This program has the potential to set a precedent for future Medicare reforms nationwide. If successful, it may expand beyond the six pilot states, affecting millions more beneficiaries. On the other hand, if the program proves burdensome, it could generate strong backlash from patients, providers, and advocacy groups alike.